Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle N Rheault

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Pediatric Nephrology (Berlin, Germany)|November 17, 2018
Correction to: Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings : A Midwest Pediatric Nephrology Consortium (MWPNC) studyJonathan H Pelletier, Karan R Kumar, Rachel Engen, et al.
Kidney Medicine|June 13, 2025
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) NetworkShikha Wadhwani, Sarah A Mansfield, Abigail R Smith, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2020
Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi SurveyCharlotte Logeman, Chandana Guha, Martin Howell, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic SyndromeRasheed A Gbadegesin, Adebowale Adeyemo, Nicholas J A Webb, et al.
The Journal of Clinical Investigation|September 3, 2024
Increased risk of kidney failure in patients with genetic kidney disordersMark D Elliott, Natalie Vena, Maddalena Marasa, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport SyndromeOliver Gross, Clifford E Kashtan, Michelle N Rheault, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2018
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H Mariani, Andrew S Bomback, Pietro A Canetta, et al.
Kidney International Reports|November 20, 2018
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN StudyDavid T Selewski, Josephine M Ambruzs, Gerald B Appel, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Genome-wide studies define new genetic mechanisms of IgA vasculitisLili Liu, Li Zhu, Sara Monteiro-Martins, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Pediatric Nephrology (Berlin, Germany)|November 17, 2018
Correction to: Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings : A Midwest Pediatric Nephrology Consortium (MWPNC) studyJonathan H Pelletier, Karan R Kumar, Rachel Engen, et al.
Kidney Medicine|June 13, 2025
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) NetworkShikha Wadhwani, Sarah A Mansfield, Abigail R Smith, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2020
Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi SurveyCharlotte Logeman, Chandana Guha, Martin Howell, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic SyndromeRasheed A Gbadegesin, Adebowale Adeyemo, Nicholas J A Webb, et al.
The Journal of Clinical Investigation|September 3, 2024
Increased risk of kidney failure in patients with genetic kidney disordersMark D Elliott, Natalie Vena, Maddalena Marasa, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport SyndromeOliver Gross, Clifford E Kashtan, Michelle N Rheault, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2018
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H Mariani, Andrew S Bomback, Pietro A Canetta, et al.
Kidney International Reports|November 20, 2018
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN StudyDavid T Selewski, Josephine M Ambruzs, Gerald B Appel, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Genome-wide studies define new genetic mechanisms of IgA vasculitisLili Liu, Li Zhu, Sara Monteiro-Martins, et al.
Pageof 8